Compare NPKI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPKI | QDEL |
|---|---|---|
| Founded | 1932 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 989.5M |
| IPO Year | 1995 | 2022 |
| Metric | NPKI | QDEL |
|---|---|---|
| Price | $8.40 | $9.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $16.33 | $15.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 126.16 | 45.35 |
| EPS | ★ 0.33 | N/A |
| Revenue | $747,763,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $9.35 | N/A |
| Revenue Next Year | $12.61 | N/A |
| P/E Ratio | $25.58 | ★ N/A |
| Revenue Growth | ★ 58.59 | N/A |
| 52 Week Low | $8.24 | $9.92 |
| 52 Week High | $16.50 | $35.58 |
| Indicator | NPKI | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 26.75 | 35.32 |
| Support Level | $8.24 | N/A |
| Resistance Level | $15.06 | $18.15 |
| Average True Range (ATR) | 0.53 | 1.22 |
| MACD | -0.03 | -0.39 |
| Stochastic Oscillator | 5.30 | 0.20 |
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.